The DOI matches its Crossref record.
IL-10 inhibits human T cell proliferation and IL-2 production
Abstract
Human IL-10 has been reported previously to inhibit the secretion of IFN-gamma in PBMC. In this study, we have found that human IL-10 inhibits T cell proliferation to either mitogen or anti-CD3 mAb in the presence of accessory cells. Inhibited T cell growth by IL-10 was associated with reduced production of IFN-gamma and IL-2. Studies of T cell subset inhibition by human IL-10 showed that CD4+, CD8+, CD45RA high, and CD45RA low cells are all growth inhibited to a similar degree. Dose response experiments demonstrated that IL-10 inhibits secretion of IFN-gamma more readily than T cell proliferation to mitogen. In addition, IL-2 and IL-4 added exogenously to IL-10 suppressed T cell cultures reversed completely the inhibition of T cell proliferation, but had little or no effect on inhibition of IFN-gamma production. Thus, in addition to its previously reported biologic properties, IL-10 inhibits human T cell proliferation and IL-2 production in response to mitogen. Inhibition of IFN-gamma production by IL-10 appears to be independent of the cytokine effect of IL-2 production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTER
Turner, D. M., Williams, D. M., Sankaran, D., Lazarus, M., Sinnott, P. J., & Hutchinson, I. V. (1997) · European Journal of Immunogenetics · doi:10.1111/j.1365-2370.1997.tb00001.x · Cited by 1,717
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,385
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
T cell responses in patients with COVID-19
Chen, Z., & John Wherry, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0402-6 · Cited by 797
Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., & Sacks, D. L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1497 · Cited by 557
Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A. (2007) · Nature Immunology · doi:10.1038/ni1540 · Cited by 529
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
Katsikis, P. D., Chu, C. Q., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1517 · Cited by 529
Properties and Functions of Interleukin-10
Mosman, T. R. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60449-6 · Cited by 500
Targeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
O'Farrell, A.-M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.1006 · Cited by 439
BOGDAN, C., & NATHAN, C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35934.x · Cited by 384
Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes
Willems, F., Marchant, A., Delville, J., Gérard, C., Delvaux, A., Velu, T., De Boer, M., & Goldman, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240435 · Cited by 376
Immune defects observed in patients with primary malignant brain tumors
Dix, A. R., Brooks, W. H., Roszman, T. L., & Morford, L. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00203-9 · Cited by 323
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., & Kiessling, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2371 · Cited by 306
Human interleukin-10 can directly inhibit T-cell growth
Taga, K., Mostowski, H., & Tosato, G. (1993) · Blood · doi:10.1182/blood.v81.11.2964.2964 · Cited by 291
Self-citationInterleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Sato, T., Terai, M., Tamura, Y., Alexeev, V., Mastrangelo, M. J., & Selvan, S. R. (2011) · Immunologic Research · doi:10.1007/s12026-011-8262-6 · Cited by 286
Human allograft acceptance is associated with immune regulation
VanBuskirk, A. M., Burlingham, W. J., Jankowska-Gan, E., Chin, T., Kusaka, S., Geissler, F., Pelletier, R. P., & Orosz, C. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9171 · Cited by 263
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
Isomäki, P., & Punnonen, J. (1997) · Annals of Medicine · doi:10.3109/07853899709007474 · Cited by 260
Regulatory NK Cells Suppress Antigen-Specific T Cell Responses
Deniz, G., Erten, G., Kücüksezer, U. C., Kocacik, D., Karagiannidis, C., Aktas, E., Akdis, C. A., & Akdis, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.850 · Cited by 256
HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis
Porto, A. F., Neva, F. A., Bittencourt, H., Lisboa, W., Thompson, R., Alcântara, L., & Carvalho, E. M. (2001) · Parasite Immunology · doi:10.1046/j.1365-3024.2001.00407.x · Cited by 120
Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy
Fox, E. M., Torrero, M. N., Evans, H., & Mitre, E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.052 · Cited by 15
Metadata
- Authors
- Taga, K., & Tosato, G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-02
- Volume
- 148
- Issue
- 4
- Pages
- 1143-1148
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1639400191
- Cited by
- 482
- References
- 0
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.